218 results on '"Daoud, J."'
Search Results
2. PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer
3. PO-1537 What factors may influence late urinary toxicities after radiation therapy of prostate cancers?
4. PO-1502 Prostate cancer in younger patients: Does it make a difference in oncological outcomes?
5. PO-1403 Dosimetric predictors of acute hematological toxicity of short course radiotherapy in rectal cancer
6. PO-1194 Social life functioning evolution during chemoradiotherapy for nasopharyngeal carcinoma
7. PO-1215 Evaluation of Sexual Health in patients with Head and Neck Cancers
8. PO-1216 Quality of weight loss during chemo-radiotherapy of nasopharyngeal carcinoma
9. PO-1210 Intensity modulated radiotherapy of nasopharyngeal carcinomas: locoregional failure patterns
10. PO-1212 How did treatment affect body image in patients treated for Head and Neck Cancers?
11. PO-1197 Dosimetric predictors of persistent xerostomia after IMRT for nasopharyngeal carcinoma
12. PO-1195 Should we delineate lacrimal gland during nasopharyngeal carcinoma radiotherapy?
13. PO-1107 Interest and respect of the dosimeter wearing in the radiotherapy department
14. PO-1103 Did the oncology resident need training on sexual health for oncology patients?
15. PO-1085 Sleep disorders in cancer patients: A missing symptom
16. PD-0086 Professional quality of life of Tunisian in training resident in oncology radiotherapy
17. PO-1563 What are the oesophagus dosimetric constraints during breast cancer hypofractionated radiotherapy?
18. PO-1562 Should we delineate brachial plexus in case of breast cancer hypofractionated radiotherapy?
19. PO-1139 Hypofractionated radiotherapy for glioblastoma: therapeutic outcomes, toxicities and quality of life
20. PO-1087 Tumour volume response to induction chemotherapy in nasopharyngeal carcinoma: TPF versus GP
21. PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
22. PO-1517 Which impact of the COVID-19 pandemic on residents training in radiotherapy?
23. PO-1466 Patients’ satisfaction during radiotherapy treatment
24. PO-1360 Are the practices of Radiation oncologists harmonious for hormone therapy in prostate cancer?
25. PO-0999 Financial difficulties during chemo-radiotherapy for nasopharyngeal carcinoma: A prospective study
26. PO-0963 How to optimize prognosis prediction of nasopharyngeal carcinoma in the era of modern radiotherapy?
27. PO-1668: Can we use cascade deep learning for GTV delineation in adaptive radiotherapy for NPC?
28. PO-1655: Dosimetric impact of the anatomical pelvic organs variations during prostate cancer IMRT
29. PO-1110: Bladder dose constraints for conformal radiotherapy in rectal cancer: adaptation to prescribed dose
30. PO-0847: Quality of life during chemo-radiotherapy for nasopharyngeal carcinoma: A prospective assessment
31. EP-2196 Dosimetric impact of anatomical changes during IMRT for prostate cancer
32. EP-1878 PRV brainstem during the nasopharyngeal IMRT: margin calculation and dosimetric implications
33. EP-1876 Level II volume and parotid doses during nasopharyngeal radiotherapy: what relationship?
34. EP-1192 Hair loss during intensity modulated radiotherapy for nasopharyngeal carcinoma
35. PO-1117 Dosimetric effect of parotid glands geometric modifications during the IMRT for NPC
36. PO-136 Haed and Neck symptoms evolution during chemo-radiotherapy: A prospective assessment
37. PO-127 How to optimize prophylactic lymph node irradiation in nasopharyngeal carcinoma?
38. PO-117 Can we reduce the posterior margins during irradiation of nasopharyngeal cancer?
39. PO-067 Should we consider the hippocampus when optimizing the IMRT of NPC?
40. PO-081 Multiple primary malignant neoplasms of head and neck
41. EP-1181: Prognostic value of lymph node and tumor necrosis in nasopharyngeal carcinoma
42. PO-092: Dosimetric comparaison of conformal and intensity modulated radiotherapy for locally recurrent NPC
43. PO-083: Adaptative radiotherapy for nasopharyngeal carcinoma
44. PO-071: Dose to the thyroid gland during irradiation of nasopharyngeal carcinoma
45. PO-070: Conventional vs bifractionated radiotherapy innasopharyngeal cancer 10years followup of phase3 trial
46. PO-060: Dose received by the pituitary gland during irradiation of nasopharyngeal carcinoma
47. Résultats thérapeutiques du cancer du cavum : y a-t-il une différence entre enfants et adultes ?
48. Le lymphome non-hodgkinien de bas grade épidural cervical primitif : à propos d’un cas et revue de la littérature
49. Formation of jarosite during Fe2+ oxidation by Acidithiobacillus ferrooxidans
50. Hypothyroïdie après irradiation cervicale dans le traitement des cancers du nasopharynx et du sein : étude prospective à propos de 84 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.